Detalhe da pesquisa
1.
Cholestatic HCV Cryoglobulinemia: A New Clinical and Pathological Entity before and after Direct-Acting Antiviral Therapies-A Case-Control Study.
Int J Mol Sci
; 25(2)2024 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38255857
2.
Beneficial effects of DAAs on cardiac function and structure in hepatitis C patients with low-moderate liver fibrosis.
J Viral Hepat
; 27(11): 1214-1221, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32593212
3.
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure.
J Hepatol
; 71(6): 1106-1115, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31433303
4.
Spur cells in liver cirrhosis are predictive of acute-on-chronic liver failure and liver-related mortality regardless of severe anaemia.
Intern Emerg Med
; 18(5): 1397-1404, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37212944
5.
The multi-drug resistant organisms infections decrease during the antimicrobial stewardship era in cirrhotic patients: An Italian cohort study.
PLoS One
; 18(2): e0281813, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795664
6.
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant.
Hepatol Commun
; 7(11)2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870985
7.
Effects of direct-acting antiviral agents on lipid and glucose profile in HCV patients with type 2 diabetes: A real-life Italian experience.
J Dig Dis
; 23(5-6): 324-330, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35700113